Latest Quarterly Earnings Summary
In Q2 2026, Danone reported total sales of €7,215 million, reflecting a like-for-like (LFL) revenue increase of 4.2% year-over-year. The growth was balanced, driven by a 1.9% contribution from volume/mix and a 2.3% gain from pricing. For the first half of 2026 (H1 2026), consolidated sales reached €13,936 million (+3.5% LFL). Recurring operating margin improved by 12 basis points to 13.3%, while recurring EPS reached €1.92 (+0.9%). Free cash flow stood at €0.9 billion, temporarily impacted by inventory security builds due to supply chain considerations.
Revenue Breakdown by Product Category and Region
Product Segments Revenue Share & Overview
- Essential Dairy and Plant-Based (EDP): Generates approximately 52% of total sales. This category includes essential daily dairy offerings (yogurts, fermented milk) and plant-based milk alternatives under brands such as Activia, Danone, Silk, and Oikos. Business performance was supported by double-digit volume growth in high-protein lines (Oikos), while North American operations continued their multi-quarter turnaround through capacity expansion.
- Specialized Nutrition: Generates approximately 30% of total sales. This high-margin segment encompasses Early Life Nutrition (infant formula) and Medical Nutrition (tube feeding, oral nutrition supplements). The segment experienced strong growth in adult and medical nutrition, alongside progressive recovery in Infant Formula following earlier supply and recall issues.
- Waters: Generates approximately 18% of total sales. This segment offers packaged natural mineral water, flavored water, and hydration products (Evian, Volvic, Aqua). Growth was led by Europe, offset by a softer performance in China due to seasonal and consumer demand factors.
Regional Revenue Share & Operational Developments
- EMEA (Europe, Middle East, Africa): Represents ~44% of total sales. Q2 LFL sales grew +3.6% (+2.2% volume/mix, +1.5% price), driven by steady dairy demand and a recovery in Infant Formula distribution.
- Americas: Represents ~31% of total sales. Q2 LFL sales grew +4.3%, with North America improving to +2.6% LFL as new yogurt manufacturing capacity came online to support core formats.
- Asia Pacific, China & Oceania (CNO): Represents ~16% of total sales. Q2 LFL sales increased +5.2%, propelled by high double-digit momentum in Specialized Nutrition, though partially moderated by soft bottled water volume in China.
- Rest of World: Represents ~9% of total sales. Demonstrated steady volume growth and pricing adjustments to address local currency fluctuations and inflation.
Key Operational Changes, Next Quarter Focus & Future Outlook
Operational Changes
Under Chapter Two of its “Renew Danone” strategic plan, the company executed several active M&A transactions in H1 2026. Key structural changes include entering an agreement to acquire MADE Group in APAC (adding over €400 million in annual sales), integrating Kate Farms in medical nutrition, acquiring Yuka in complete nutrition, and establishing a dairy joint venture with Arcor in Argentina.
Next Quarter Focus Points
- Cost Inflation & Selective Pricing: Managing input cost pressures stemming from commodity volatility via selective pricing actions in H2 2026.
- EDP North America Capacity: Monitoring the rollout of expanded yogurt production lines to meet demand for protein platforms (Oikos).
- APAC Hydration Dynamics: Observing demand recovery in the Chinese bottled water category alongside the execution of newly announced APAC acquisitions.
Future Outlook
Danone reconfirmed its full-year 2026 financial guidance:
- Like-for-like sales growth expected between 3.0% and 5.0%.
- Recurring operating income growth targeted to outpace overall sales growth, supported by continuous productivity gains and portfolio optimization.
Three-Month Stock Price Performance & Drivers
Over the past three months (mid-May 2026 to mid-August 2026), Danone’s share price (BN.PA) traded within a range of approximately €60.90 to €74.00, closing near €65.24 on August 17, 2026.
- May to Early June 2026: Shares traded in a trough between €60.90 and €63.50 amid macro volatility in broad consumer staples.
- Late June to Mid-July 2026: The stock experienced a strong rally, reaching a multi-month peak near €74.00 in early July 2026. This upward movement was fueled by market anticipation of strong second-quarter volume momentum and positive strategic progress under the Renew Danone strategy.
- Late July to Mid-August 2026: Following the H1/Q2 earnings announcement on July 29, 2026, the stock retraced toward the €65.00–€68.00 range. Despite solid 4.2% Q2 LFL growth beating baseline expectations, profit-taking occurred as investors digested cost inflation comments for H2 and temporary free cash flow compression linked to safety inventory builds.
Sources
- https://www.perplexity.ai/finance/BN.PA/earnings
- https://www.investing.com/news/company-news/danone-q2-2026-slides-sales-growth-accelerates-to-42-93CH-4818774
- https://www.finanzwire.com/article/danone-epa-bn-danone-reports-strong-q2-and-solid-h1-2026-results-a0MkNv10r0M
- https://tradingeconomics.com/bn:fp